Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada
· Delayed Price · Currency is CAD 0.1800
0.00 (0.00%)
Aug 15, 2025, 2:05 PM EDT
Rapid Dose Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is March - February.
Millions CAD. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | 2018 - 2020 |
| Net Income | -4.87 | -5.4 | -4.31 | -3.81 | -8.49 | -1.81 | Upgrade
|
| Depreciation & Amortization | 0.29 | 0.24 | 0.62 | 0.63 | 0.77 | 0.68 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 4.08 | - | Upgrade
|
| Stock-Based Compensation | 1.13 | 1.42 | 0.16 | 0.71 | 1.7 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -0.01 | 0.02 | - | - | Upgrade
|
| Other Operating Activities | 1.07 | 1.08 | 0.75 | 0.13 | 0.15 | 0.07 | Upgrade
|
| Change in Accounts Receivable | 0.04 | -0.08 | -0.07 | 0.02 | 0.2 | -0.14 | Upgrade
|
| Change in Inventory | -0.1 | -0.11 | 0.01 | 0.08 | -0.04 | -0.19 | Upgrade
|
| Change in Accounts Payable | 1.37 | 1.64 | 0.62 | 1.31 | -0.47 | 0.45 | Upgrade
|
| Change in Unearned Revenue | - | - | -0.01 | -0.01 | -0.88 | -0.63 | Upgrade
|
| Change in Other Net Operating Assets | 0.11 | 0.07 | -0.06 | 0.06 | -0.02 | -0.05 | Upgrade
|
| Operating Cash Flow | -0.96 | -1.15 | -2.29 | -0.86 | -3 | -1.62 | Upgrade
|
| Capital Expenditures | -0.01 | -0.01 | - | - | -0.04 | -0.01 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | - | - | - | 0 | - | Upgrade
|
| Cash Acquisitions | - | - | - | - | 1.89 | - | Upgrade
|
| Investing Cash Flow | -0 | -0.01 | - | - | 1.85 | -0.01 | Upgrade
|
| Short-Term Debt Issued | - | - | 0.43 | 0.81 | 0.13 | 1.1 | Upgrade
|
| Long-Term Debt Issued | - | - | 1.83 | 0.2 | - | - | Upgrade
|
| Total Debt Issued | 0.09 | - | 2.26 | 1.01 | 0.13 | 1.1 | Upgrade
|
| Short-Term Debt Repaid | - | -0.25 | -0.7 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.13 | -0.34 | -0.31 | -0.29 | -0.26 | Upgrade
|
| Total Debt Repaid | -0.35 | -0.38 | -1.04 | -0.31 | -0.29 | -0.26 | Upgrade
|
| Net Debt Issued (Repaid) | -0.26 | -0.38 | 1.22 | 0.7 | -0.16 | 0.84 | Upgrade
|
| Issuance of Common Stock | 0.81 | 1.39 | 1.3 | 0.15 | 1.28 | 0.9 | Upgrade
|
| Other Financing Activities | 0.38 | - | -0.09 | - | - | -0.09 | Upgrade
|
| Financing Cash Flow | 0.93 | 1.01 | 2.43 | 0.86 | 1.13 | 1.65 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | 0 | -0.02 | 0.05 | Upgrade
|
| Net Cash Flow | -0.04 | -0.14 | 0.13 | -0.01 | -0.04 | 0.07 | Upgrade
|
| Free Cash Flow | -0.97 | -1.15 | -2.29 | -0.86 | -3.04 | -1.63 | Upgrade
|
| Free Cash Flow Margin | -39.09% | -55.27% | -224.91% | -120.27% | -173.52% | -216.20% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.02 | -0.01 | -0.03 | -0.02 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.08 | 0.07 | 0.14 | Upgrade
|
| Levered Free Cash Flow | -0.1 | -0.21 | -1.89 | 0.55 | -1.55 | -1.11 | Upgrade
|
| Unlevered Free Cash Flow | 0.62 | 0.56 | -1.48 | 0.72 | -1.47 | -1.02 | Upgrade
|
| Change in Working Capital | 1.42 | 1.52 | 0.49 | 1.46 | -1.21 | -0.56 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.